Thomas K - Search Results

1

Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Saif MW, et al. Among authors: thomas k. J Gastrointest Oncol. 2019 Aug;10(4):674-687. doi: 10.21037/jgo.2019.03.11. J Gastrointest Oncol. 2019. PMID: 31392048 Free PMC article.

2

Management of pulmonary neuroendocrine tumors.

Ramirez RA, Chauhan A, Gimenez J, Thomas KEH, Kokodis I, Voros BA. Ramirez RA, et al. Rev Endocr Metab Disord. 2017 Dec;18(4):433-442. doi: 10.1007/s11154-017-9429-9. Rev Endocr Metab Disord. 2017. PMID: 28868578 Review.

3

Quality of life for non-small cell lung cancer patients in the age of immunotherapy.

Ramirez RA, Lu J, Thomas KEH. Ramirez RA, et al. Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S149-S152. doi: 10.21037/tlcr.2018.03.10. Transl Lung Cancer Res. 2018. PMID: 29782567 Free PMC article. No abstract available.

4

Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.

Thomas KEH, Voros BA, Boudreaux JP, Thiagarajan R, Woltering EA, Ramirez RA. Thomas KEH, et al. Oncologist. 2019 Aug;24(8):1076-1088. doi: 10.1634/theoncologist.2018-0604. Epub 2019 Jan 11. Oncologist. 2019. PMID: 30635447 Free PMC article. Review.

5

Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs).

Thomas K, Voros BA, Meadows-Taylor M, Smeltzer MP, Griffin R, Boudreaux JP, Thiagarajan R, Woltering EA, Ramirez RA. Thomas K, et al. Cancers (Basel). 2020 Jan 14;12(1):206. doi: 10.3390/cancers12010206. Cancers (Basel). 2020. PMID: 31947598 Free PMC article.

6

Adjuvant therapy for lung neuroendocrine neoplasms.

Ramirez RA, Thomas K, Jacob A, Lin K, Bren-Mattison Y, Chauhan A. Ramirez RA, et al. Among authors: thomas k. World J Clin Oncol. 2021 Aug 24;12(8):664-674. doi: 10.5306/wjco.v12.i8.664. World J Clin Oncol. 2021. PMID: 34513600 Free PMC article. Review.

7

A Peptide Meets a Radionuclide to Combat a Rare Tumor.

Thomas KE, Boudreaux JP, Thiagarajan R, Marsala A, Voros BA, Ramirez RA. Thomas KE, et al. Ochsner J. 2021 Fall;21(3):306-311. doi: 10.31486/toj.20.0098. Ochsner J. 2021. PMID: 34566515 Free PMC article.

8

External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.

Das S, Chauhan A, Du L, Thomas KE, Jacob A, Schad A, Jain S, Jessop A, Shah C, Eisner D, Cardin DB, Ciombor KK, Goff LW, Bradshaw M, Delbeke D, Sandler M, Ramirez RA, Berlin J. Das S, et al. Among authors: thomas ke. JAMA Netw Open. 2022 Jan 4;5(1):e2144170. doi: 10.1001/jamanetworkopen.2021.44170. JAMA Netw Open. 2022. PMID: 35044469 Free PMC article.

9

A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review.

Ramirez RA, Cass AS, Das S, Low SW, Mehrad M, Rickman OB, Scherer PM, Thomas KE, Gillaspie EA. Ramirez RA, et al. Transl Lung Cancer Res. 2022 Dec;11(12):2567-2587. doi: 10.21037/tlcr-22-415. Transl Lung Cancer Res. 2022. PMID: 36636417 Free PMC article. Review.

10

Utilization of Nivolumab in Adenoid Cystic Carcinoma After Progression on Platinum-Based Chemotherapy.

Maslov DV, Thomas K, Matrana M. Maslov DV, et al. Among authors: thomas k. Perm J. 2021 May;25:20.229. doi: 10.7812/TPP/20.229. Perm J. 2021. PMID: 33970093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,154 results

Search Page